EFFECTS OF 1-KETO AND 1-HYDROXY DERIVATIVES OF 3-METHYLCHOLANTHRENE UPON LIVER DRUG METABOLIZING ENZYME ACTIVITY

被引：3

作者：

BRESNICK, E

SMITH, S

SEIBERT, RA

机构：

来源：

关键词：

D O I：

10.1016/0006-2952(70)90272-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2469 / &

共 24 条

[1] BRESNICK E, 1967, CANCER RES, V27, P462
[2] BRESNICK E, 1969, 4 INT C PHARM
[3] CONNEY AH, 1960, J PHARMACOL EXP THER, V130, P1
[4] CONNEY AH, 1960, J PHARMACOL EXP THER, V128, P333
[5] FACTORS INFLUENCING DRUG METABOLISM
CONNEY, AH
BURNS, JJ
[J]. ADVANCES IN PHARMACOLOGY, 1962, 1 : 31 - 58
[6] CRAMER JW, 1960, J BIOL CHEM, V235, P250
[7] EFFECT OF BENZO[A]PYRENE DERIVATIVES UPON DRUG METABOLISING ENZYME ACTIVITIES
DEWHURST, F
KITCHEN, DA
[J]. BIOCHEMICAL PHARMACOLOGY, 1969, 18 (04) : 942 - &
[8] The oxidation of methylcholanthrene and 3,4-benzpyrene with lead tetraacetate, further derivatives of 3,4-benzpyrene
Fieser, LF
Hershberg, EB
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1938, 60 : 2542 - 2548
[9] GELBOIN HC, 1968, ADV CANCER RES, V8, P1
[10] GELBOIN HV, 1969, JERUSALEM S QUANTUM, V1, P175